UNC2025
产品编号: DC7931
Featured
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
UNC2025 是一种强效、高口服活性的 Mer/Flt3 抑制剂，IC50 值分别为 0.74 nM 和 0.8 nM。UNC2025 对MERTK 的选择性是 Axl 的 45 倍 (IC50=122 nM; Ki=13.3 nM)。UNC2025 具有良好的 PK 特性，可用于急性白血病的研究。
| Cas No.: |
1429881-91-3 |
| 名称: |
(1r,4r)-4-(2-(butylamino)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexanol |
| 别名: |
UNC-2025; UNC2025; UNC 2025. |
| SMILES: |
[C@@H](O)1CC[C@H](N2C3C(C(C4=CC=C(CN5CCN(C)CC5)C=C4)=C2)=CN=C(NCCCC)N=3)CC1 |
| 分子式: |
C28H40N6O |
| 分子量: |
476.66 |
| 纯度: |
|
| 保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: |
|
| In Vivo: |
|
| In Vitro: |
|
| References: |
UNC2025 was capable of inhibiting Mer phosphorylation in vivo, following oral dosing as demonstrated by pharmaco-dynamic (PD) studies examining phospho-Mer in leukemic blasts from mouse bone marrow. Kinome pro?ling versus more than 300 kinases in vitro an |
| Kinase Assay: |
|
| Cell Assay: |
|
| Animal Administration: |
|
| References: |
|
MSDS
COA
| LOT NO. |
DOWNLOAD |
|
|
| 2018-0101 |
|
询盘
